Dose-finding trial paves way for new rotavirus vaccine to prevent a deadly diarrheal disease from birth — ScienceDaily
A phase 2 clinical trial has found that the Australian-developed neonatal rotavirus vaccine RV3-BB was safe and produced a robust immune response in African babies. The immune response generated was…
